These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 37344)

  • 61. Properties of particulate, membrane-associated and soluble guanylate cyclase from cardiac muscle, skeletal muscle, cerebral cortex and liver.
    Sulakhe SJ; Leung NL; Sulakhe PV
    Biochem J; 1976 Sep; 157(3):713-9. PubMed ID: 10891
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Suppression of DNA synthesis in mice by the anthracycline antibiotics daunorubicin, carminomycin and doxorubicin].
    Reznikova MI; Dudnik IuV
    Antibiot Khimioter; 1988 Apr; 33(4):286-9. PubMed ID: 3389958
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of adenylate cyclase inhibitor (ACI) on guanylate cyclase, phosphodiesterase and other enzymes in heart.
    Lehotay DC; Levey GS; Vesely DL; Bornet EP; Ray MV; Entman ML; Schwartz A
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):55-65. PubMed ID: 14979
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tannic acid ameliorates doxorubicin-induced cardiotoxicity and potentiates its anti-cancer activity: potential role of tannins in cancer chemotherapy.
    Tikoo K; Sane MS; Gupta C
    Toxicol Appl Pharmacol; 2011 Mar; 251(3):191-200. PubMed ID: 21194538
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
    Chou TH; Kessel D
    Biochem Pharmacol; 1981 Nov; 30(22):3134-6. PubMed ID: 6950722
    [No Abstract]   [Full Text] [Related]  

  • 66. The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin.
    Rogalska A; Gajek A; Szwed M; Jóźwiak Z; Marczak A
    Toxicol In Vitro; 2011 Dec; 25(8):1712-20. PubMed ID: 21896327
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Enantioselective synthesis of anthracyclines].
    Monneret C
    Ann Pharm Fr; 1997; 55(1):5-11. PubMed ID: 9138316
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture.
    Kuffel MJ; Reid JM; Ames MM
    Cancer Chemother Pharmacol; 1992; 30(1):51-7. PubMed ID: 1586980
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Current status of studies with adriamycin (NSC-123127).
    Bachur NR
    Cancer Chemother Rep 3; 1973 May; 4(3):47-50. PubMed ID: 4795942
    [No Abstract]   [Full Text] [Related]  

  • 70. Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia.
    Inaba M; Johnson RK
    Biochem Pharmacol; 1978; 27(17):2123-30. PubMed ID: 31880
    [No Abstract]   [Full Text] [Related]  

  • 71. Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism.
    Cusack BJ; Gambliel H; Musser B; Hadjokas N; Shadle SE; Charlier H; Olson RD
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):517-26. PubMed ID: 16555089
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Magnesium protection against anthracycline toxicity in vitro.
    Zdanowicz MM; Barletta MA
    Magnes Res; 1991 Jun; 4(2):105-7. PubMed ID: 1911091
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect.
    Schlage P; Mezo G; Orbán E; Bosze S; Manea M
    J Control Release; 2011 Dec; 156(2):170-8. PubMed ID: 21864594
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intracellular glutathione as a determinant of responsiveness to antitumor drugs.
    Romine MT; Kessel D
    Biochem Pharmacol; 1986 Oct; 35(19):3323-6. PubMed ID: 3464280
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract]   [Full Text] [Related]  

  • 76. Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3.
    Hofman J; Malcekova B; Skarka A; Novotna E; Wsol V
    Toxicol Appl Pharmacol; 2014 Aug; 278(3):238-48. PubMed ID: 24832494
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Doxorubicin- and daunorubicin-induced regulation of Ca2+ and H+ fluxes through human bax inhibitor-1 reconstituted into membranes.
    Yun CH; Chae HJ; Kim HR; Ahn T
    J Pharm Sci; 2012 Mar; 101(3):1314-26. PubMed ID: 22147501
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tetrahydropyranyl derivatives of daunomycin and adriamycin.
    Umezawa H; Takahashi Y; Kinoshita M; Naganawa H; Masuda T; Ishizuka M; Tatsuta K; Takeuchi T
    J Antibiot (Tokyo); 1979 Oct; 32(10):1082-4. PubMed ID: 528373
    [No Abstract]   [Full Text] [Related]  

  • 79. Cardiotoxic effects of anthracyclines.
    Bristow MR
    West J Med; 1983 Sep; 139(3):369-71. PubMed ID: 18749444
    [No Abstract]   [Full Text] [Related]  

  • 80. Acute negative inotropic effect of adriamycin (doxorubicin).
    Höfling B; Bolte HD
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):252-6. PubMed ID: 7322214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.